Dehydroepiandrosterone Stimulates Phosphorylation of FoxO1 in Vascular Endothelial Cells via Phosphatidylinositol 3-Kinase- and Protein Kinase A-dependent Signaling Pathways to Regulate ET-1 Synthesis and Secretion

This publication has 79 references indexed in Scilit:

• Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?
  Expert Opinion on Therapeutic Targets, 2008
• Effect of dehydroepiandrosterone on insulin sensitivity in Otsuka Long-Evans Tokushima-fatty rats
  Acta Diabetologica, 2007
• Comment on: Hosagai et al. (2007) Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation: Diabetes 56:901–911
  Diabetes, 2007
• Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007
• Treatment of Spontaneously Hypertensive Rats With Rosiglitazone and/or Enalapril Restores Balance Between Vasodilator and Vasoconstrictor Actions of Insulin With Simultaneous Improvement in Hypertension and Insulin Resistance
  Diabetes, 2006
• Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells
  Proceedings of the National Academy of Sciences, 2006
• Dehydroepiandrosterone Activates Endothelial Cell Nitric-oxide Synthase by a Specific Plasma Membrane Receptor Coupled to Gαi2,3
  Journal of Biological Chemistry, 2002
• Interaction of Endothelin‐1 and Nitric Oxide in Endothelial Barrier Failure in the Cat Hindlimb
  Microcirculation, 2000
• Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.
  Journal of Clinical Investigation, 1988
• A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular Disease
  New England Journal of Medicine, 1986